BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6875024)

  • 1. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Kogan FJ; Sampliner RE; Mayersohn M; Kazama RM; Perrier D; Jones W; Michael UF
    J Clin Pharmacol; 1983; 23(5-6):252-6. PubMed ID: 6875024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine clearance during intermittent and chronic peritoneal dialysis.
    Hyneck ML; Murphy JF; Lipschutz DE
    Am J Hosp Pharm; 1981 Nov; 38(11):1760-2. PubMed ID: 7304634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal dialysis clearance of cimetidine.
    Vaziri ND; Ness RL; Barton CH
    Am J Gastroenterol; 1979 Jun; 71(6):572-6. PubMed ID: 313152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
    Pizzella KM; Moore MC; Schultz RW; Walshe J; Schentag JJ
    Ther Drug Monit; 1980; 2(3):273-81. PubMed ID: 7222181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
    Bliss M; Mayersohn M; Arnold T; Logan J; Michael UF; Jones W
    Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral absorption of cimetidine and its clearance in patients with renal failure.
    Larsson R; Bodemar G; Norlander B
    Eur J Clin Pharmacol; 1979 Apr; 15(3):153-7. PubMed ID: 456399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
    Larsson R; Erlanson P; Bodemar G; Norlander B; Fransson L; Strouth L
    Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Chin TW; Pancorbo S; Comty C
    Clin Exp Dial Apheresis; 1981; 5(4):391-7. PubMed ID: 7341025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
    Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
    Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of foscarnet during peritoneal dialysis.
    Alexander AC; Akers A; Matzke GR; Aweeka FT; Fraley DS
    Ann Pharmacother; 1996 Oct; 30(10):1106-9. PubMed ID: 8893116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine dynamics after single intravenous doses.
    Pancorbo S; Bubrick MP; Chin TW; Miller KW; Onstad G
    Clin Pharmacol Ther; 1982 Jan; 31(1):83-8. PubMed ID: 7053310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
    Burgess ED; Gill MJ
    J Clin Pharmacol; 1990 Nov; 30(11):997-1000. PubMed ID: 2243158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
    Arvidsson A; Alván G; Tranaeus A; Malmborg AS
    Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.